Larimar Therapeutics (LRMR) Shares Outstanding (2013 - 2025)

Larimar Therapeutics' Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $9.5 million for Q4 2025.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $9.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.5 million (changed N/A YoY) and the FY2025 annual result came in at $9.5 million, changed N/A from the prior year.
• Shares Outstanding (Entity) was $9.5 million for Q4 2025 at Larimar Therapeutics, down from $25.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $25.8 million in Q4 2022 and bottomed at $9.5 million in Q4 2025.
• A 3-year average of $17.7 million and a median of $17.7 million in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 392.19% — and 2022, when it gained 15.24%.
• Larimar Therapeutics' Shares Outstanding (Entity) stood at $17.7 million in 2021, then jumped by 45.46% to $25.8 million in 2022, then sank by 62.98% to $9.5 million in 2025.
• Business Quant data shows LRMR's Shares Outstanding (Entity) at $9.5 million in Q4 2025, $25.8 million in Q4 2022, and $22.2 million in Q3 2022.